379 related articles for article (PubMed ID: 34919227)
1. The potential of gut microbiome as a non-invasive predictive biomarker for early detection of pancreatic cancer and hepatocellular carcinoma.
Kaźmierczak-Siedlecka K; Stachowska E; Folwarski M; Przewłócka K; Makarewicz W; Bryl E
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7275-7284. PubMed ID: 34919227
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota: A new piece in understanding hepatocarcinogenesis.
Zhou A; Tang L; Zeng S; Lei Y; Yang S; Tang B
Cancer Lett; 2020 Apr; 474():15-22. PubMed ID: 31917160
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.
Ren Z; Li A; Jiang J; Zhou L; Yu Z; Lu H; Xie H; Chen X; Shao L; Zhang R; Xu S; Zhang H; Cui G; Chen X; Sun R; Wen H; Lerut JP; Kan Q; Li L; Zheng S
Gut; 2019 Jun; 68(6):1014-1023. PubMed ID: 30045880
[TBL] [Abstract][Full Text] [Related]
4. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.
Jiang JW; Chen XH; Ren Z; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):19-27. PubMed ID: 30527903
[TBL] [Abstract][Full Text] [Related]
5. The microbiota and microbiome in pancreatic cancer: more influential than expected.
Wei MY; Shi S; Liang C; Meng QC; Hua J; Zhang YY; Liu J; Zhang B; Xu J; Yu XJ
Mol Cancer; 2019 May; 18(1):97. PubMed ID: 31109338
[TBL] [Abstract][Full Text] [Related]
6. Human microbiome is a diagnostic biomarker in hepatocellular carcinoma.
Rao BC; Lou JM; Wang WJ; Li A; Cui GY; Yu ZJ; Ren ZG
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):109-115. PubMed ID: 32037278
[TBL] [Abstract][Full Text] [Related]
7. The microbiome and hepatobiliary-pancreatic cancers.
Mima K; Nakagawa S; Sawayama H; Ishimoto T; Imai K; Iwatsuki M; Hashimoto D; Baba Y; Yamashita YI; Yoshida N; Chikamoto A; Baba H
Cancer Lett; 2017 Aug; 402():9-15. PubMed ID: 28527946
[TBL] [Abstract][Full Text] [Related]
8. Research progress of gut microbiota in hepatocellular carcinoma.
Li K; Liu J; Qin X
J Clin Lab Anal; 2022 Jul; 36(7):e24512. PubMed ID: 35719048
[TBL] [Abstract][Full Text] [Related]
9. Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer.
Mendez R; Kesh K; Arora N; Di Martino L; McAllister F; Merchant N; Banerjee S; Banerjee S
Carcinogenesis; 2020 Jul; 41(5):561-570. PubMed ID: 31369062
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome.
Temraz S; Nassar F; Kreidieh F; Mukherji D; Shamseddine A; Nasr R
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360566
[TBL] [Abstract][Full Text] [Related]
11. Altered gut microbiota in hepatocellular carcinoma: Insights into the pathogenic mechanism and preclinical to clinical findings.
Das BK
APMIS; 2022 Dec; 130(12):719-740. PubMed ID: 36321381
[TBL] [Abstract][Full Text] [Related]
12. The Gut Microbiome and Hepatocellular Carcinoma.
Akkız H
J Gastrointest Cancer; 2021 Dec; 52(4):1314-1319. PubMed ID: 34870783
[TBL] [Abstract][Full Text] [Related]
13. Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse model.
Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A
BMC Microbiol; 2021 Apr; 21(1):113. PubMed ID: 33858327
[TBL] [Abstract][Full Text] [Related]
14. The gut microbiome and liver cancer: mechanisms and clinical translation.
Yu LX; Schwabe RF
Nat Rev Gastroenterol Hepatol; 2017 Sep; 14(9):527-539. PubMed ID: 28676707
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory Milieu Related to Dysbiotic Gut Microbiota Promotes Tumorigenesis of Hepatocellular Carcinoma.
Huang C; Mei S; Zhang X; Tian X
J Clin Gastroenterol; 2023 Sep; 57(8):782-788. PubMed ID: 37406184
[TBL] [Abstract][Full Text] [Related]
16. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma.
Zheng R; Wang G; Pang Z; Ran N; Gu Y; Guan X; Yuan Y; Zuo X; Pan H; Zheng J; Wang F
Cancer Med; 2020 Jun; 9(12):4232-4250. PubMed ID: 32281295
[TBL] [Abstract][Full Text] [Related]
17. Dysbiosis of Gut Microbiota Promotes Hepatocellular Carcinoma Progression by Regulating the Immune Response.
Zhang N; Gou Y; Liang S; Chen N; Liu Y; He Q; Zhang J
J Immunol Res; 2021; 2021():4973589. PubMed ID: 34722779
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiome in HCC - Mechanisms, diagnosis and therapy.
Schwabe RF; Greten TF
J Hepatol; 2020 Feb; 72(2):230-238. PubMed ID: 31954488
[TBL] [Abstract][Full Text] [Related]
19. New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer.
Ezzaidi N; Zhang X; Coker OO; Yu J
Cancer Lett; 2019 Sep; 459():186-191. PubMed ID: 31185249
[TBL] [Abstract][Full Text] [Related]
20. The gut microbiome-bile acid axis in hepatocarcinogenesis.
Wu L; Feng J; Li J; Yu Q; Ji J; Wu J; Dai W; Guo C
Biomed Pharmacother; 2021 Jan; 133():111036. PubMed ID: 33378947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
